Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysisNatalie J Ives, Stefan Suciu, Alexander M M Eggermont, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's diseaseRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
Lancet (London, England)|June 15, 2014
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial, Richard Gray, Natalie Ives, et al.
British Journal of Haematology|September 10, 2011
Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trialBrenda E S Gibson, David K H Webb, Andrew J Howman, et al.
British Journal of Haematology|May 30, 2012
The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AMLAlan K Burnett, Nigel H Russell, Dominic Culligan, et al.
Future Oncology (London, England)|March 9, 2013
Intensity-modulated arc therapy to improve radiation dose delivery in the treatment of abdominal neuroblastomaJennifer E Gains, Christopher Stacey, Ivan Rosenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastomaJennifer E Gains, Veronica Moroz, Matthew D Aldridge, et al.
JAMA Neurology|January 20, 2016
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical TrialCarl E Clarke, Smitaa Patel, Natalie Ives, et al.
Contemporary Clinical Trials Communications|April 24, 2019
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancersJim Murray, Guy Pratt, Abe Jacob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapyPeter J Campbell, David Bareford, Wendy N Erber, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysisNatalie J Ives, Stefan Suciu, Alexander M M Eggermont, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's diseaseRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
Lancet (London, England)|June 15, 2014
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial, Richard Gray, Natalie Ives, et al.
British Journal of Haematology|September 10, 2011
Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trialBrenda E S Gibson, David K H Webb, Andrew J Howman, et al.
British Journal of Haematology|May 30, 2012
The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AMLAlan K Burnett, Nigel H Russell, Dominic Culligan, et al.
Future Oncology (London, England)|March 9, 2013
Intensity-modulated arc therapy to improve radiation dose delivery in the treatment of abdominal neuroblastomaJennifer E Gains, Christopher Stacey, Ivan Rosenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastomaJennifer E Gains, Veronica Moroz, Matthew D Aldridge, et al.
JAMA Neurology|January 20, 2016
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical TrialCarl E Clarke, Smitaa Patel, Natalie Ives, et al.
Contemporary Clinical Trials Communications|April 24, 2019
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancersJim Murray, Guy Pratt, Abe Jacob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapyPeter J Campbell, David Bareford, Wendy N Erber, et al.
Pageof 15